Concepedia

Joshua D. Freedman

JD

Statistics

Publications

8

Citations

1.5K

H-Index

8

Active since

2017

Affiliations

Institute of Molecular Biology and Pathology(Current)

King's College London

European Bioinformatics Institute

King's College Hospital NHS Foundation Trust

London School of Hygiene & Tropical Medicine

Joshua D. Freedman is an author at Institute of Molecular Biology and Pathology specializing in t cell immunity, immune system, and autoimmunity.

ORCID

Top concepts

Publications per year

2017–2020

8

Publications

8

A dynamic COVID-19 immune signature includes associations with poor prognosis

Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio et al. · Nature Medicine · 2020 · 1K citations · Full text

An Oncolytic Virus Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells

Joshua D. Freedman, Margaret R. Duffy, Janet Lei-Rossmann et al. · Cancer Research · 2018 · 160 citations · Full text

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies

Joshua D. Freedman, Joachim Hagel, Eleanor M. Scott et al. · EMBO Molecular Medicine · 2017 · 116 citations · Full text

Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples

Eleanor M. Scott, Egon J. Jacobus, Brian Lyons et al. · Journal for ImmunoTherapy of Cancer · 2019 · 72 citations · Full text

Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis

Adam G. Laing, Anna Lorenc, Irene del Molino del Barrio et al. · Nature Medicine · 2020 · 67 citations · Full text

1–5 of 8